Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia

References

• Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract. 2007;106:c72–81.
   PubMedGoogle Scholar
• Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension. 2005;46:1077–85.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lewis DF, Alexander JS, Granger DN. Endothelial barrier function in preeclampsia. Front Biosci. 2007;12:2412–24.
   PubMed Web of Science ®Google Scholar
• Heilmann L, Rath W, Pollow K. Hemostatic abnormalities in patients with severe preeclampsia. Clin Appl Thromb Hemost. 2007;13:285–91.
   PubMed Web of Science ®Google Scholar
• Wickstrom K, Edelstam G, Lowbeer CH, Hansson LO, Siegbahn A. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest. 2004;64:31–40.
   PubMed Web of Science ®Google Scholar
• Konijnenberg A, Stokkers EW, van der Post JA, Schaap MC, Boer K, Bleker OP, Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol. 1997;176:461–9.
   PubMed Web of Science ®Google Scholar
• Holthe MR, Staff AC, Berge LN, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol. 2004;190:1128–34.
   PubMed Web of Science ®Google Scholar
• Williams VK, Griffiths AB, Carbone S, Hague WM. Fibrinogen concentration and factor VIII activity in women with preeclampsia. Hypertens Pregnancy. 2007;26:415–21.
   PubMed Web of Science ®Google Scholar
• Manten GT, Sikkema JM, Franx A, Hameeteman TM, Visser GH, de Groot PG, Increased high molecular weight fibrinogen in pre-eclampsia. Thromb Res. 2003;111:143–7.
   PubMed Web of Science ®Google Scholar
• Sahni A, Khorana AA, Baggs RB, Peng H, Francis CW. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood. 2006;107:126–31.
   PubMed Web of Science ®Google Scholar
• Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–904.
   PubMed Web of Science ®Google Scholar
• Leung LL. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest. 1986;77:1305–11.
   PubMed Web of Science ®Google Scholar
• Saigo K, Yoshida A, Ryo R, Yamaguchi N, Leung LL. Histidine-rich glycoprotein as a negative acute phase reactant. Am J Hematol. 1990;34:149–50.
   PubMedGoogle Scholar
• Jespersen J. Monitoring plasma antithrombin-III levels during infusion of antithrombin-III concentrate. Thromb Haemost. 1984;52:214.
   Google Scholar
• Tsuchida-Straeten N, Ensslen S, Schafer C, Woltje M, Denecke B, Moser M, Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost. 2005;3:865–72.
   PubMedGoogle Scholar
• Dixelius J, Olsson AK, Thulin A, Lee C, Johansson I, Claesson-Welsh L. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. Cancer Res. 2006;66:2089–97.
   Google Scholar
• Lee C, Dixelius J, Thulin A, Kawamura H, Claesson-Welsh L, Olsson AK. Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. Exp Cell Res. 2006;312:2547–56.
   Google Scholar
• Halbmayer WM, Hopmeier P, Feichtinger C, Rubi K, Fischer M. Histidine-rich glycoprotein (HRG) in uncomplicated pregnancy and mild and moderate preeclampsia. Thromb Haemost. 1992;67:585–6.
   Google Scholar
• von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143–8.
   PubMed Web of Science ®Google Scholar
• Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG. 2006;113:580–9.
   PubMed Web of Science ®Google Scholar
• Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51:970–5.
   PubMed Web of Science ®Google Scholar
• Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late- onset preeclampsia. Obstet Gynecol. 2007;109:1368–74.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–83.
   PubMed Web of Science ®Google Scholar
• Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008;59:61–78.
   PubMed Web of Science ®Google Scholar
• Kanfer A, Bruch JF, Nguyen G, He CJ, Delarue F, Flahault A, Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest. 1996;74:253–8.
   PubMed Web of Science ®Google Scholar
• Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre- eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;31:303–9.
   PubMed Web of Science ®Google Scholar
• Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;121:154–8.
   PubMed Web of Science ®Google Scholar
• Jones AL, Hulett MD, Parish CR. Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol. 2005;83:106–18.
   PubMed Web of Science ®Google Scholar
• Vanwildemeersch M, Olsson AK, Gottfridsson E, Claesson-Welsh L, Lindahl U, Spillmann D. The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent manner. J Biol Chem. 2006;281:10298–304.
   Google Scholar
• Leung LL, Harpel PC, Nachman RL, Rabellino EM. Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood. 1983;62:1016–21.
   PubMedGoogle Scholar
• Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond). 1994;86:731–9.
   PubMed Web of Science ®Google Scholar
• Raijmakers MT, Peters WH, Steegers EA, Poston L. NAD(P)H oxidase associated superoxide production in human placenta from normotensive and pre-eclamptic women. Placenta. 2004;25(Suppl A):S85–9.
   Google Scholar
• Bremme K, Ostlund E, Almqvist I, Heinonen K, Blomback M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol. 1992;80:132–7.
   PubMed Web of Science ®Google Scholar